Plasma Lipoprotein Response to Glucagon-like Peptide-2
Clinical trial NCT03422666 · COMPLETED
Trial details
- NCT number
- NCT03422666
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-21
- Primary completion
- 2021-06-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.